Practice question

Differentiated roots possess endodermis, pericycle, and organized transport tissues that compartmentalize biosynthetic pathways and sequester toxic end products safely in vacuoles. Hairy root cultures preserve this organization while displaying exponential growth in hormone-free liquid, combining advantages of organized tissue and microbial-like scalability. Many pharmaceuticals like atropine, scopolamine, withanolides, and tanshinones are synthesized primarily in root cortex and stored in vacuoles, so root cultures maintain expression of pathway genes including putrescine N-methyltransferase and hyoscyamine 6β-hydroxylase at higher levels than dedifferentiated callus where such transcription factors are downregulated. Biomass stability and ability to be elicited by jasmonates further boost yield. Consequently hairy root systems have become preferred platform for commercial secondary metabolite production, offering controllable, year-round, GMP-compliant source of root-derived bioactive compounds. Comparative RNA-seq of hairy roots versus callus shows upregulation of root-specific MYB transcription factors and pathway genes like tropinone reductase. Elicitors such as methyl jasmonate activate jasmonate ZIM-domain degradation, releasing MYC2 to boost alkaloid biosynthesis. Stability over extended subcultures ensures consistent product profile, supporting commercial application for pharmaceutical production without seasonal variation.